Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 26:2020:9131474.
doi: 10.1155/2020/9131474. eCollection 2020.

Update on the Management of Parkinson's Disease for General Neurologists

Affiliations
Review

Update on the Management of Parkinson's Disease for General Neurologists

Zvezdan Pirtošek et al. Parkinsons Dis. .

Abstract

Management of Parkinson's disease (PD) is complicated due to its progressive nature, the individual patient heterogeneity, and the wide range of signs, symptoms, and daily activities that are increasingly affected over its course. The last 10-15 years have seen great progress in the identification, evaluation, and management of PD, particularly in the advanced stages. Highly specialized information can be found in the scientific literature, but updates do not always reach general neurologists in a practical and useful way, potentially creating gaps in knowledge of PD between them and neurologists subspecialized in movement disorders, resulting in several unmet patient needs. However, general neurologists remain instrumental in diagnosis and routine management of PD. This review provides updated practical information to identify problems and resolve common issues, particularly when the advanced stage is suspected. Some tips are provided for efficient communication with the members of a healthcare team specialized in movement disorders, in order to find support at any stage of the disease in a given patient, and especially for a well-timed decision on referral.

PubMed Disclaimer

Conflict of interest statement

ZP reports personal fees from Abbvie, outside the submitted work; OB reports grants and personal fees from Abbvie, outside the submitted work; NK reports personal fees from Medtronic, Boehringer Ingelheim, Novartis, GlaxoSmithKline, UCB, Krka, and Abbvie, outside the submitted work; IM reports personal fees from Abbvie, outside the submitted work; MS reports personal fees and non-financial support from Medtronic, Sandoz, Egis, UCB Abbvie and Shire, and grants, personal fees and/or non-financial support from International Parkinson and Movement Disorder Society, Slovak Research and Development Agency, outside the submitted work. All authors report non-financial support from Abbvie (Medical Writing services) for the present work.

Figures

Figure 1
Figure 1
Summary diagram of Parkinson's disease diagnosis based on the diagnostic criteria of the movement disorder society [7].

References

    1. Dorsey E. R., Constantinescu R., Thompson J. P., et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384–386. doi: 10.1212/01.wnl.0000247740.47667.03. - DOI - PubMed
    1. de Lau L. M., Breteler M. M. Epidemiology of Parkinson’s disease. The Lancet Neurology. 2006;5(6):525–535. doi: 10.1016/s1474-4422(06)70471-9. - DOI - PubMed
    1. Okun M. S. Management of Parkinson disease in 2017. JAMA. 2017;318(9):791–792. doi: 10.1001/jama.2017.7914. - DOI - PubMed
    1. Willis A. W., Schootman M., Tran R., et al. Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology. 2012;79(17):1774–1780. doi: 10.1212/wnl.0b013e3182703f92. - DOI - PMC - PubMed
    1. National Institute for Health and Care Excellence. NICE Guideline Parkinson’s Disease in Adults. London, UK: NICE; 2017. 1.2 diagnosing Parkinson’s Disease. https://www.nice.org.uk/guidance/ng71/chapter/Recommendations#diagnosing....

LinkOut - more resources